Physician

Joseph Eugene Huffstutter, M.D.

According to 2025 Medicare claims, Joseph Huffstutter, M.D. (NPI: 1902840788) practices rheumatology in the Chattanooga, TN-GA market, with the plurality of this provider's patient population coming from Hamilton, TN. This provider's primary affiliated billing organization is ARTHRITIS ASSOCIATES (NPI: 1982647962) and primary practice location at 37343-7908. Huffstutter is affiliated with the Mission Health Partners, LLC (ACO ID: A2591) and Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Huffstutter's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 589 traditional Medicare patients, billed 189,762 HCPCS/CPT codes, and received $2,121,968 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,637 prescription claims across 719 beneficiaries totaling $2,728,863 in drug costs, led by Strensiq (Asfotase Alfa). 2022 DME data shows 11 claims. Open Payments data shows 267 records totaling $93,658. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	684	149,438	$2,200,147
2016	679	126,612	$2,428,750
2017	657	127,543	$2,710,176
2018	627	130,830	$2,749,078
2019	654	180,786	$2,756,025
2020	684	189,268	$2,881,838
2021	646	160,056	$2,430,176
2022	651	150,045	$1,971,844
2023	635	202,834	$2,173,491
2024	589	189,762	$2,121,968

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	580	7,051	$1,537,584
2016	548	7,278	$1,289,068
2017	521	6,863	$1,338,315
2018	508	6,103	$1,301,957
2019	504	5,385	$1,289,853
2020	650	5,788	$1,116,824
2021	680	5,666	$1,146,300
2022	665	5,234	$976,563
2023	685	5,330	$1,760,742
2024	719	5,637	$2,728,863

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	12	$128
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	24	$1,482
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	11	$240
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	432	1,096	$86
80053	Blood test, comprehensive group of blood chemicals	486	1,191	$10
36415	Insertion of needle into vein for collection of blood sample	500	1,290	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	486	1,227	$8
85652	Red blood cell sedimentation rate, to detect inflammation, automated	425	964	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Strensiq	Asfotase Alfa	13	364	$1,820,329
Rinvoq	Upadacitinib	22	780	$163,039
Enbrel Sureclick	Etanercept	16	448	$111,754
Orencia	Abatacept	11	308	$72,734
Benlysta	Belimumab	12	336	$61,206

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	266	$58,336	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$35,322	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joseph Eugene Huffstutter, M.D.?

Tedicare shows public-source Medicare data for Joseph Eugene Huffstutter, M.D. (NPI 1902840788), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph Eugene Huffstutter, M.D. have ACO affiliation data?

Joseph Eugene Huffstutter, M.D. is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591) and Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Joseph Eugene Huffstutter, M.D.?

Joseph Eugene Huffstutter, M.D. is linked to ARTHRITIS ASSOCIATES (billing NPI 1982647962) in the available physician profile data.

Does Joseph Eugene Huffstutter, M.D. have Open Payments data?

Joseph Eugene Huffstutter, M.D. has 267 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.